Fucruz will prioritize studies on monkeypox

Fucruz will prioritize studies on monkeypox

The Foundation has reduced the deadline for approval of research registration to less than 48 hours

The Vuecruz (Oswaldo Cruz Foundation) announced on Thursday (1st.set.2022) that it will give priority to studies in monkey pox.

The institution, which is responsible for administering ReBEC (Brazilian Register of Clinical Trials), has published an express consent method, also known as fast trackwhich gives preference to research that investigates the disease.

In practice, the procedure reduces the approval time for research, which is mandatory in all cases, to less than 48 hours. According to Fiocruz, depending on the number of studies to be registered in the country, the deadline can be up to weeks.

The fast track It was first adopted in Brazil in 2016 during an epidemic Zika virus. The disease is transmitted by mosquitoes Aedes aegypti. Currently, other diseases, such as COVID-19And the dengue feverAnd the ChikungunyaAnd the yellow fever And the malaria Designed too.

Monkey Box

to me Our world in dataAs of Thursday (September 1), Brazil had recorded 5,197 cases of monkeypox. On the same day, the second death from the disease was recorded in the country.

Since May, the world The largest spread of the virus outside Africa.

a 360 . force prepared reportage Explanation of monkeypox.

Read symptoms, transmission methods, prevention and treatment:

See also  Two-thirds of Sao Paulo cities did not record Covid-19 deaths in the past week

By Andrea Hargraves

"Wannabe internet buff. Future teen idol. Hardcore zombie guru. Gamer. Avid creator. Entrepreneur. Bacon ninja."